ArticleTherapeutic advances in medical oncology2021

Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with

Pham Van Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.